Results 61 to 70 of about 727,398 (339)

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

open access: yesMolecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert   +13 more
wiley   +1 more source

Dark-ages Reionization & Galaxy Formation Simulation VIII. Suppressed growth of dark matter halos during the Epoch of Reionization

open access: yes, 2017
We investigate how the hydrostatic suppression of baryonic accretion affects the growth rate of dark matter halos during the Epoch of Reionization. By comparing halo properties in a simplistic hydrodynamic simulation in which gas only cools adiabatically,
Angel, Paul W.   +7 more
core   +1 more source

Predictors of response and rational combinations for the novel MCL‐1 inhibitor MIK665 in acute myeloid leukemia

open access: yesMolecular Oncology, EarlyView.
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad   +17 more
wiley   +1 more source

Too Hot, Too Cold or Just Right? Implications of a 21-cm Signal for Dark Matter Annihilation and Decay [PDF]

open access: yes, 2018
Measurements of the temperature of the baryons at the end of the cosmic dark ages can potentially set very precise constraints on energy injection from exotic sources, such as annihilation or decay of the dark matter.
Liu, Hongwan, Slatyer, Tracy R.
core   +2 more sources

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

open access: yesMolecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece   +18 more
wiley   +1 more source

Survivin and Aurora Kinase A control cell fate decisions during mitosis

open access: yesMolecular Oncology, EarlyView.
Aurora A interacts with survivin during mitosis and regulates its centromeric role. Loss of Aurora A activity mislocalises survivin, the CPC and BubR1, leading to disruption of the spindle checkpoint and triggering premature mitotic exit, which we refer to as ‘mitotic slippage’.
Hana Abdelkabir   +2 more
wiley   +1 more source

Dark-Ages Reionisation & Galaxy Formation Simulation XVI: The Thermal Memory of Reionisation

open access: yes, 2019
Intergalactic medium temperature is a powerful probe of the epoch of reionisation, as information is retained long after reionisation itself. However, mean temperatures are highly degenerate with the timing of reionisation, with the amount heat injected ...
Davies, James E.   +5 more
core   +1 more source

Class IIa HDACs forced degradation allows resensitization of oxaliplatin‐resistant FBXW7‐mutated colorectal cancer

open access: yesMolecular Oncology, EarlyView.
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto   +13 more
wiley   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

The Impact of Foregrounds on Dark Ages Measurements with the Highly Redshifted 21 cm Line

open access: yesThe Astrophysical Journal
Studies of the cosmic dark ages (30 ≲  z  ≲ 150) using the highly redshifted 21 cm line of neutral hydrogen offer unparalleled amounts of cosmological information, and recent years have seen the refinement of concepts for such experiments (e.g., CoDEX ...
Jonathan C. Pober, Willow Smith
doaj   +1 more source

Home - About - Disclaimer - Privacy